Evidence map›Paper›PMID 34548310›Full record

ArticleCancer discovery2022

Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated Fibroblasts.

Erin J Helms, Mark W Berry, R Crystal Chaw, Christopher C DuFort, Duanchen Sun, M Kathrina Onate, Chet Oon, Sohinee Bhattacharyya, Hannah Sanford-Crane, Wesley Horton and 7 more

Open access · greenAbstract read
In one paragraph

Article in Cancer discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 161 papers.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 217 citations in OpenAlex.

  1. Article
  2. SDC1Gut · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Glutamine-dependent changes in fibroblast-derived extracellular matrix dictate cancer cell behavior.Matrix biology : journal of the International Society for Matrix Biology · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Erin J HelmsDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Mark W BerryDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.
R Crystal ChawAdvanced Light Microscopy Shared Resource, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0003-4200-6518
Christopher C DuFortClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Duanchen SunDepartment of Computational Biology, Oregon Health & Science University, Portland, Oregon.
M Kathrina OnateDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0003-3495-6038
Chet OonDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Sohinee BhattacharyyaDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Hannah Sanford-CraneDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0003-0049-5026
Wesley HortonDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Jennifer M FinanDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0001-7706-1643
Ariana SattlerDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Rosemary MakarKnight BioLibrary, Oregon Health & Science University, Portland, Oregon.
David W DawsonDepartment of Pathology and Laboratory Medicine and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California.ORCID 0000-0002-0215-5861
Zheng XiaDepartment of Computational Biology, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0003-3364-8324
Sunil R HingoraniClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0002-3869-8729
Mara H ShermanDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon. shermama@ohsu.edu.
Oregon Health & Science University · USFred Hutch Cancer Center · USUniversity of California, Los Angeles · USUniversity of Washington Medical Center · US

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Grace B Gill · 1997 to 2026
$60.5M
OVERCOMING STROMAL BARRIERS TO THERAPEUTICS IN PANCREAS CANCERR01CA161112 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Sunil R Hingorani · 2011 to 2026
$7.6M
Program in Molecular and Cellular BiosciencesT32GM071338 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MASLEN, CHERYL L · 2005 to 2020
$3.5M
Stopping PDA progression using inhibitors of CSC dissemination and immunotherapyU01CA224193 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HINGORANI, SUNIL R · 2017 to 2021
$3.3M
Origins and functions of pancreatic cancer-associated fibroblastsR01CA250917 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Mara H. Sherman · 2021 to 2026
$2.3M
HaemAPA: Characterizing alternative polyadenylation in human blood cellsR21HL145426 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI XIA, ZHENG · 2019 to 2020
$231k
NCI NIH HHS P30 CA069533NCI NIH HHS R01 CA161112NCI NIH HHS R01 CA250917NCI NIH HHS U01 CA224193NHLBI NIH HHS R21 HL145426NIGMS NIH HHS T32 GM071338
6 · The paper itself

Abstract

Cancer-associated fibroblast (CAF) heterogeneity is increasingly appreciated, but the origins and functions of distinct CAF subtypes remain poorly understood. The abundant and transcriptionally diverse CAF population in pancreatic ductal adenocarcinoma (PDAC) is thought to arise from a common cell of origin, pancreatic stellate cells (PSC), with diversification resulting from cytokine and growth factor gradients within the tumor microenvironment. Here we analyzed the differentiation and function of PSCs during tumor progression

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCancer-Associated FibroblastsFemaleHumansMaleMesenchymal Stem CellsMicePancreatic Neoplasms

Identifiers

PMID34548310
PMCPMC8831457
OpenAlexW3199988150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.